We are looking for children 2–17 years of age to join a trial to help us discover more about treating gastrointestinal disease. If you are looking for a potential new treatment option for gastrointestinal disease or Crohn’s and ulcerative colitis (including associated symptoms such as abdominal cramps, fatigue, rectal pain, frequent fevers and/or liver disease), consider one of our IBD studies. All eligible participants will receive no-cost study-related care and study medication. Your children 2–17 years of age may be eligible to take part.
Your child may be eligible to take part in the IBD studies if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Find out if your child may be able to to join.
